Impact of splenomegaly on therapeutic response and I-131-LYM-1 dosimetry in patients with B-lymphocytic malignancies. [electronic resource]
- Cancer Dec 1997
- 2553-7 p. digital
Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
0008-543X
10.1002/(sici)1097-0142(19971215)80:12+<2553::aid-cncr30>3.3.co;2-n doi